Tuberculosis and Respiratory Diseases最新文献

{"title":"Importance of accounting for confounding factors when assessing cardiovascular outcomes of COVID-19: a nationwide cohort study.","authors":"Seung-Hun You, Moon Seong Baek, Tae Wan Kim, Gyungah Kim, Sun-Young Jung, Won-Young Kim","doi":"10.4046/trd.2025.0092","DOIUrl":"https://doi.org/10.4046/trd.2025.0092","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Decade of Healthcare Quality Assessment for Chronic Obstructive Pulmonary Disease in South Korea: Trends and Implications (2014-2023).","authors":"Hyeon-Kyoung Koo, Chin Kook Rhee, Kyung Hoon Min, Ji-Yong Moon, Yong Il Hwang, Yong Bum Park, Deog Kyeom Kim","doi":"10.4046/trd.2025.0030","DOIUrl":"https://doi.org/10.4046/trd.2025.0030","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder associated with substantial morbidity and healthcare costs. Effective outpatient management can prevent exacerbations and reduce hospitalization rates. Since 2014, the South Korean government has conducted annual COPD quality assessment to improve disease management and ensure high-quality healthcare services. The results of the 9th COPD quality assessment, conducted between January and December 2023, were recently published.</p><p><strong>Methods: </strong>Healthcare institutions providing outpatient services for COPD (ICD-10 codes J43, J44 except J43.0) were evaluated based on pulmonary function test (PFT) rates, rate of continuous outpatient visits, and inhaled bronchodilator prescription rates. The monitoring indices included COPD-related hospitalization, emergency room (ER) visits, and duration of inhaled bronchodilator prescriptions.</p><p><strong>Results: </strong>A total of 6,339 institutions and 158,906 patients were assessed in 2023. The PFT rate increased from 58.7% in 2014 to 80.3% in 2023, with the highest rates observed in tertiary hospitals (92.0%) and the lowest in clinics (53.6%). The inhaled bronchodilator prescription rate reached 91.5%, demonstrating a continuous improvement in pharmacological therapy. However, the rate of continuous outpatient visits declined to 80.2%, and COPD-related hospitalization (10.8%) and ER visits (6.4%) increased, indicating persistent gaps in outpatient management.</p><p><strong>Conclusion: </strong>The COPD quality assessment program has significantly improved diagnostic and pharmacological management; however, it highlights ongoing challenges in rate of continuous outpatient visits. Addressing regional disparities, strengthening primary care, and increasing public awareness are essential for the optimization of COPD management. Future efforts should focus on enhancing the implementation of PFTs and ensuring adequate reimbursement for inhaler education.</p>","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Disease Activity and Cumulative Damage as Treatment Targets for COPD.","authors":"Yeon-Mok Oh","doi":"10.4046/trd.2025.0033","DOIUrl":"https://doi.org/10.4046/trd.2025.0033","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144498108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nationwide Quality Assessment of Lung Cancer Management in Korea: Based on Second-Cycle Health Insurance Review and Assessment Service (HIRA) Evaluation.","authors":"Seunghun Lee, So-Yun Kim, Cheol-Kyu Park, Seong-Hoon Yoon, Chaeuk Chung, Sung Yong Lee","doi":"10.4046/trd.2025.0038","DOIUrl":"https://doi.org/10.4046/trd.2025.0038","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer remains the leading cause of cancer-related mortality worldwide. To improve lung cancer care quality, the Health Insurance Review and Assessment Service (HIRA) in Korea conducted the first phase of the second-cycle adequacy assessment, incorporating patient-centered and outcome-based indicators.</p><p><strong>Methods: </strong>This study analyzed HIRA claims data from 106 medical institutions treating lung cancer between July 2022 and June 2023. The assessment evaluated treatment adequacy based on structural, procedural, and outcome indicators across tertiary care hospitals, general hospitals, and clinics.</p><p><strong>Results: </strong>The second-cycle evaluation adopted a comprehensive framework, incorporating multidisciplinary care and end-of-life management. Among 21,517 cases, 44 tertiary care hospitals managed 75.9%, while 62 general hospitals handled 24.1%. The average adequacy score was 91.09, with 80.7% of institutions rated Grade 1. The multidisciplinary consultation rate was 30.8%, exceeding the 12.6% target. Surgery within 30 days of diagnosis was performed in 93.2% of cases, and the overall surgical mortality rate was 1.19%, lower in tertiary care hospitals (1.04%) than in general hospitals (1.88%). The 30-day readmission rate was 2.26%, and 56.8% of patients received hospice counseling.</p><p><strong>Conclusion: </strong>The second-cycle assessment emphasized patient-centered and outcome-based care, integrating multidisciplinary consultation and hospice indicators. These findings suggest that lung cancer treatment institutions in South Korea maintain high adequacy standards. Continuous improvements will be necessary to align with medical advancements and enhance lung cancer management.</p>","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to Daungsupawong et al.","authors":"Sang Hyuk Kim, Hyun Lee, Min Ji Kim, Min Gu Kang, Jong Seung Kim, Jong Geol Jang, Youlim Kim, Hyeon-Kyoung Koo, Chin Kook Rhee, Kyung Hoon Min, Yong Il Hwang, Deog Kyeom Kim, Yong Bum Park, Ji-Yong Moon","doi":"10.4046/trd.2025.0089","DOIUrl":"https://doi.org/10.4046/trd.2025.0089","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Vaccination on Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Correspondence.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.4046/trd.2025.0035","DOIUrl":"https://doi.org/10.4046/trd.2025.0035","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144326981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clarifying Geriatric Nutrition Risk Index Classification in Critically Ill Patients with Severe Coronavirus Disease 2019.","authors":"Sheng-Yi Lin, Hsiang-Lan Yu, Hsin-Hsia Lu, Hui-Yu Wu, Shu-Yun Wu, Kuo-Hsien Tseng, Chih-Chung Shiao","doi":"10.4046/trd.2025.0075","DOIUrl":"https://doi.org/10.4046/trd.2025.0075","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clarifying GNRI Classification in Severe COVID-19: Response to Shiao et al.","authors":"Hye Ju Yeo, Woo Hyun Cho","doi":"10.4046/trd.2025.0093","DOIUrl":"https://doi.org/10.4046/trd.2025.0093","url":null,"abstract":"","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144276019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacoeconomic inequalities in access to antifibrotic treatment for interstitial lung disease in the Asia-Pacific region.","authors":"Felix Chua, Larry Ellee Nyanti, Shirin Tan, Syazatul Syakirin Sirol Aflah, Sze Shyang Kho, Gin Tsen Chai, Amornpun Wangkarnjana, Su-Ying Low, Sita Andarini, Lutz Beckert, Celeste May Campomanes, Florence Kp Chan, Sally De Boer, Supparerk Disayabutr, Dina Diaz, Fanny Fachrucha, Nicole Goh, Tomohiro Handa, Adelle Jee, Kamon Kawkitinarong, Hsin-Kuo Ko, Valencia Lim, John Mackintosh, Noorul Afidza Muhammad, Moo Suk Park, Eric Tenda, Ying-Ming Tsai, Catherine Joy Tubig, Le Thuong Vu, Trang Vu, Margaret Wilsher, Wing-Ho Yip, Yoshizaku Inoue, Jin Woo Song","doi":"10.4046/trd.2025.0056","DOIUrl":"https://doi.org/10.4046/trd.2025.0056","url":null,"abstract":"<p><p>Antifibrotic drugs, available for the best part of the last decade in many parts of the world, has improved outcomes in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. However, it is unclear whether patients suffering from these devastating conditions have timely and adequate access to antifibrotic therapy in the Asia Pacific region (APAC). In this mixed-methods narrative review of 12 APAC countries, integration of questionnaire-based insights of 31 regional clinical experts in interstitial lung disease (ILD) with publicly available pharmaco-economic information has been used to understand how country-specific challenges impact on antifibrotic accessibility. Overall, a broad range of approaches are utilised to provide antifibrotic treatment including centrally or state-determined drug budgets, pharmaceutical industry-subsidised initiatives, charitable support and self-paying (out-of-pocket) options. Impediments to antifibrotic access commonly arise from prohibitive drug pricing in relation to income, absence of universal coverage for pharmaceutical costs, lack of formal pharmaco-economic analysis or restrictions on the use of generic preparations. Unequal access to antifibrotic drugs is a vital unmet therapeutic need in the APAC region, one that is likely to be exacerbated by a rising fibrotic interstitial lung disease burden.</p>","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144267313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases.","authors":"Chul Park, Yoomi Yeo, A La Woo, Jung Wan Yoo, Goohyeon Hong, Jong Wook Shin, Sung Woo Park","doi":"10.4046/trd.2025.0044","DOIUrl":"https://doi.org/10.4046/trd.2025.0044","url":null,"abstract":"<p><p>Interstitial lung disease (ILD) comprises a heterogeneous group of disorders characterized by interstitial compartment proliferation, inflammatory infiltration, and potential fibrosis with abnormal collagen deposition. Diagnosis requires a multidisciplinary consensus integrating clinical, radiological, and pathological findings. Idiopathic interstitial pneumonia (IIP) includes idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (NSIP), desquamative interstitial pneumonia (DIP), acute interstitial pneumonia (AIP), and respiratory bronchiolitis-ILD (RB-ILD), each exhibiting distinct prognostic and therapeutic implications. Some non-IPF ILDs progress despite standard treatment, classified as progressive fibrosing interstitial lung disease (PF-ILD) or progressive pulmonary fibrosis (PPF), diagnosed by worsening symptoms, physiological decline, and radiological progression. Nintedanib is conditionally recommended for refractory PPF cases. Combined pulmonary fibrosis and emphysema (CPFE) is characterized by upper-lobe predominant emphysema and lower-lobe fibrosis, frequently complicated by pulmonary hypertension and lung cancer. Interstitial lung abnormality (ILA), observed in both smokers and the general population, is associated with increased mortality and disease risk, warranting further research. Despite advancements, refinement in classification, diagnostic criteria, and therapeutic strategies remains crucial for improving patient outcomes.</p>","PeriodicalId":23368,"journal":{"name":"Tuberculosis and Respiratory Diseases","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144182552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}